Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BlueSky Immunotherapies logo — Next generation virotherapy against cancer and infectious di...

BlueSky Immunotherapies

Next generation virotherapy against cancer and infectious diseases

Founded 2016 Austria Austria 2 employees Biotechnology

General Information

Company Name BlueSky Immunotherapies
Founded Year 2016
Location Austria Austria +1
Employees 2
Industries Biotechnology
Social

Get notified when BlueSky Immunotherapies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BlueSky Immunotherapies

BlueSky Immunotherapies GmbH (Ltd.) is a biotech company located in Vienna that was founded in 2017. The company is focused on developing next-generation virotherapy against cancer and infectious diseases. BlueSky's proprietary technology platform is centered around interferon-inducing viral vectors (delNS), which have immunostimulatory and antiviral properties. This innovative approach allows BlueSky to target therapies against cancer and various viral infectious diseases. BlueSky Immunotherapies is well-positioned in the biotechnology sector, leveraging its unique technology to address critical medical needs. The company’s proprietary platform and therapeutic focus demonstrate its potential to have a significant impact on the field of immunotherapy. Given the promising nature of BlueSky's work, it is a compelling opportunity for venture capital investment. The innovative technology, coupled with the company's dedication to addressing cancer and viral infectious diseases, makes it a strong contender for potential investment. As the biotech industry continues to evolve, BlueSky Immunotherapies stands out as a company with the potential to make a meaningful contribution to the advancement of medical treatment options.

Taxonomy: Virotherapy, Immunotherapy, Cancer Treatment, Tumor Cell Killing, Oncolytic Viruses, Immunomodulatory Cytokines, Tumor Associated Antigens, Selective Replication, Prime/Boost Scenario, Immunosuppression, Antiviral Therapy, Interferon Therapy, Cancer Immunotherapy, Oncolytic Vaccine

No funding data available for BlueSky Immunotherapies yet.

Get notified when BlueSky Immunotherapies raises funding

BlueSky Immunotherapies Alternatives & Competitors

BlueSky Immunotherapies vs
VacV Biotherapeutics
VacV Biotherapeutics United Kingdom

Developing oncolytic viruses as therapeutics for cancer

Seed
6 employees
Biotechnology, Health Care
BlueSky Immunotherapies vs
VYROBIO
VYROBIO Brazil

Developing next-generation viral immunotherapies to treat aggressive, fast-growing forms of CNS tumo...

Seed
9 employees
Biotechnology
BlueSky Immunotherapies vs
Memgen, Inc.
Memgen, Inc. United States

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

Series Unknown
7 employees
Biotechnology, Health Care
Also compare with: BlueSky Immunotherapies vs GeneMedicine GeneMedicine

FAQ About BlueSky Immunotherapies

Next generation virotherapy against cancer and infectious diseases
BlueSky Immunotherapies was founded in 2016.
BlueSky Immunotherapies is headquartered in Austria.
BlueSky Immunotherapies operates in the following industries: Biotechnology.
BlueSky Immunotherapies has approximately 2 employees.
Top alternatives and competitors to BlueSky Immunotherapies include VacV Biotherapeutics, VYROBIO, Memgen, Inc., GeneMedicine, VAXIMM AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BlueSky Immunotherapies and VacV Biotherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BlueSky Immunotherapies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes